Dr. Amritha Jaishankar is the Executive Director of the Cell and Gene Therapy Center at IQVIA. Her focus is on accelerating the development and commercialization of cell and gene therapies for companies and research institutions. She leads an integrated and collaborative approach to support IQVIA’s cell and gene portfolio through disruptive innovation, strategic partnerships, and growth initiatives. With over 18 years of experience in stem cell and cell therapy programs in academic, non-profit, government, and industry settings, Dr. Jaishankar is a proven leader and champion for cell therapy research and commercialization.

Dr. Jaishankar’s leadership, innovative mindset, and unique approach to global collaborations and partnerships have been instrumental in advancing the development and commercialization of promising regenerative medicine technologies.

Previously, Dr. Jaishankar served as the Executive Director of the Maryland Stem Cell Research Fund. Her leadership, passion, and expertise were critical in establishing the organization as Maryland’s premier entity to identify, invest in, and foster cell-based technologies. She led the fund to its highest visibility and budget in over a decade and developed Maryland’s first cell therapy manufacturing assistance program. Dr. Jaishankar’s work has supported over 200 academic and industry projects, moved over 100 technologies towards commercialization, and helped create and grow numerous companies.